Ocular implant system and method
View Patent ↗A method of treating glaucoma in a human eye by inserting a distal exit port of a cannula at least partially into Schlemm's canal of the eye; delivering a dye through the cannula into Schlemm's canal; identifying obstructions within Schlemm's canal; and delivering an ocular implant through the cannula into Schlemm's canal.
1. A method of treating glaucoma in a human eye comprising:
inserting a distal exit port of a cannula at least partially into Schlemm's canal of the eye;
delivering a dye through the cannula into Schlemm's canal;
identifying obstructions within Schlemm's canal; and
delivering an ocular implant through the cannula into Schlemm's canal.
2. The method of claim 1 further comprising inserting a tool into the cannula, the step of delivering a dye comprising delivering a dye through the tool.
3. The method of claim 2 further comprising moving the tool and the ocular implant with respect to each other within Schlemm's canal.
4. The method of claim 2 wherein the ocular implant delivering step comprises delivering the ocular implant over the tool.
5. The method of claim 2 further comprising opening a channel in Schlemm's canal with the tool.
6. The method of claim 5 wherein the opening step comprises moving the tool within Schlemm's canal.
7. The method of claim 5 wherein the opening step comprises delivering a fluid through the tool.
8. The method of claim 7 further comprises moving the fluid through an obstruction within Schlemm's canal to increase fluid communication between adjacent segments of Schlemm's canal.
9. The method of claim 7 wherein the fluid comprises a dilatation agent adapted to dilate tissue within the Schlemm's canal portion.
10. The method of claim 7 wherein the fluid comprises a therapeutic agent.
11. The method of claim 1 wherein the ocular implant delivering step and the dye delivering step comprise delivering the dye and the ocular implant without removing the distal exit port of the cannula from the eye.
12. The method of claim 1 wherein the inserting step comprises inserting the distal exit port of the cannula at least partially into Schlemm's canal of the eye through an ab interno approach.
13. The method of claim 1 wherein the inserting step comprises inserting the distal exit port of the cannula at least partially into Schlemm's canal of the eye through an ab externo approach.
14. A method of treating glaucoma in a human eye comprising:
inserting a distal exit port of a cannula at least partially into Schlemm's canal of the eye;
injecting a dye through the cannula into Schlemm's canal;
as the dye is injected into Schlemm's canal, observing movement of the dye within Schlemm's canal to identify obstructions within Schlemm's canal; and
delivering an ocular implant through the cannula into Schlemm's canal.
15. The method of claim 14 wherein the injecting step and the delivering step are performed without removing the distal exit port of the cannula from the eye.
16. The method of claim 14 wherein the inserting step comprises inserting the distal exit port of the cannula at least partially into Schlemm's canal of the eye through an ab interno approach.
17. The method of claim 14 further comprising inserting a tool into the cannula, the step of injecting a dye comprising injecting a dye through the tool.
18. The method of claim 17 further comprising opening a channel in Schlemm's canal with the tool.
19. The method of claim 18 wherein the opening step comprises moving the tool within Schlemm's canal.
20. The method of claim 18 wherein the opening step comprises delivering a fluid through the tool.